MedPath

Study on the clinical efficacy evaluation of acupuncture and Chinese medicine combined with weight loss in the treatment of polycystic ovary syndrome

Not Applicable
Conditions
polycystic ovarian syndrome
Registration Number
ITMCTR2200006709
Lead Sponsor
Shenzhen Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Conform to Chinese or Western diagnosis of polycystic ovary syndrome with insulin resistance.
2. Women aged 20-40 years with no pregnancy plan in the future 6 months.
3. Body mass index (BMI) = weight/height^2 (kg/m^2) >= 24.
4. Voluntary participation and signed informed consent.
5. Have the ability to use a smartphone to cooperate with medical weight loss online guidance and follow-up.
6. If using hormonal medication, the medication should be stopped for more than 3 months.

Exclusion Criteria

1. Those who do not meet the inclusion criteria or do not take the drug as prescribed or have poor compliance.
2. Patients who are participating in clinical trials of other drugs.
3. Have recently taken hormonal drugs or other western drugs
4. Have obvious organic lesions or malformations of the reproductive system, or serious systemic diseases such as cardiovascular, endocrine, liver, kidney and hematopoietic system and other important organ lesions and psychiatric patients, as confirmed by examination test measurements.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ovulation rates;weight;
Secondary Outcome Measures
NameTimeMethod
fasting blood sugar;fasting insulin;TC/TG/HDL/LDL;FSH/LH/E2/PRL/T;
© Copyright 2025. All Rights Reserved by MedPath